Search research articles
Contact Us
Filters
Showing results (91-100 of 105) with videos related to
Page
of 11
Sort By:
Cancer Research
|
October 19, 2011
Lactoferrin-endothelin-1 axis contributes to the development and invasiveness of triple-negative breast cancer phenotypes
Ngoc-Han Ha, Vasudha S Nair, Divijendra Natha Sirigiri Reddy, et al.
Theranostics
|
October 12, 2020
Truncated HDAC9 identified by integrated genome-wide screen as the key modulator for paclitaxel resistance in triple-negative breast cancer
Bi Lian, Yu-Chen Pei, Yi-Zhou Jiang, et al.
Journal of the National Cancer Institute
|
November 5, 2020
Molecular Features and Functional Implications of Germline Variants in Triple-Negative Breast Cancer
Ding Ma, Si-Yu Chen, Jin-Xiao Ren, et al.
The Journal of Clinical Investigation
|
April 29, 2025
Kinesin-like protein KIFC2 stabilizes CDK4 to accelerate growth and confer resistance in HR+/HER2- breast cancer
Shao-Ying Yang, Ming-Liang Jin, Lisa Andriani, et al.
Breast Cancer Research : BCR
|
March 16, 2016
Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer
Yi-Rong Liu, Yi-Zhou Jiang, Xiao-En Xu, et al.
Cell Research
|
February 2, 2022
Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
Yi Xiao, Ding Ma, Yun-Song Yang, et al.
Cell Metabolism
|
November 12, 2020
Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targets
Yue Gong, Peng Ji, Yun-Song Yang, et al.
Cell Metabolism
|
March 12, 2022
The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer
Hai Wang, Xingyu Rong, Gan Zhao, et al.
Cancer Research
|
April 28, 2018
PHF5A Epigenetically Inhibits Apoptosis to Promote Breast Cancer Progression
Yi-Zi Zheng, Meng-Zhu Xue, Hong-Jie Shen, et al.
Cell Reports
|
March 2, 2022
Proteome-centric cross-omics characterization and integrated network analyses of triple-negative breast cancer
Tian-Qi Gong, Yi-Zhou Jiang, Chen Shao, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 105) with videos related to
Sort By:
Page
of 11
Cancer Research
|
October 19, 2011
Lactoferrin-endothelin-1 axis contributes to the development and invasiveness of triple-negative breast cancer phenotypes
Ngoc-Han Ha, Vasudha S Nair, Divijendra Natha Sirigiri Reddy, et al.
Theranostics
|
October 12, 2020
Truncated HDAC9 identified by integrated genome-wide screen as the key modulator for paclitaxel resistance in triple-negative breast cancer
Bi Lian, Yu-Chen Pei, Yi-Zhou Jiang, et al.
Journal of the National Cancer Institute
|
November 5, 2020
Molecular Features and Functional Implications of Germline Variants in Triple-Negative Breast Cancer
Ding Ma, Si-Yu Chen, Jin-Xiao Ren, et al.
The Journal of Clinical Investigation
|
April 29, 2025
Kinesin-like protein KIFC2 stabilizes CDK4 to accelerate growth and confer resistance in HR+/HER2- breast cancer
Shao-Ying Yang, Ming-Liang Jin, Lisa Andriani, et al.
Breast Cancer Research : BCR
|
March 16, 2016
Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer
Yi-Rong Liu, Yi-Zhou Jiang, Xiao-En Xu, et al.
Cell Research
|
February 2, 2022
Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
Yi Xiao, Ding Ma, Yun-Song Yang, et al.
Cell Metabolism
|
November 12, 2020
Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targets
Yue Gong, Peng Ji, Yun-Song Yang, et al.
Cell Metabolism
|
March 12, 2022
The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer
Hai Wang, Xingyu Rong, Gan Zhao, et al.
Cancer Research
|
April 28, 2018
PHF5A Epigenetically Inhibits Apoptosis to Promote Breast Cancer Progression
Yi-Zi Zheng, Meng-Zhu Xue, Hong-Jie Shen, et al.
Cell Reports
|
March 2, 2022
Proteome-centric cross-omics characterization and integrated network analyses of triple-negative breast cancer
Tian-Qi Gong, Yi-Zhou Jiang, Chen Shao, et al.
Page
of 11